Back to GetFilings.com




 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 10-Q

 

þ                                     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE                                 

SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2003

 

OR

 

¨                                         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE                            

SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                     to                             

 

Commission file number 333-76473

 


 

EQUISTAR CHEMICALS, LP

(Exact name of registrant as specified in its charter)

 

Delaware

 

76-0550481

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No.)

1221 McKinney Street,

 

77010

Suite 700, Houston, Texas

 

(Zip Code)

(Address of principal executive offices)

   

 

Registrant’s telephone number, including area code: (713) 652-7200

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ü     No     

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes         No  ü

There is no established public trading market for the registrant’s equity securities.

 



PART I.    FINANCIAL INFORMATION

 

EQUISTAR CHEMICALS, LP

 

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

 

    

For the three months ended March 31,


 

Millions of dollars


  

2003


    

2002


 

Sales and other operating revenues:

                 

Trade

  

$

1,227

 

  

$

895

 

Related parties

  

 

414

 

  

 

241

 

    


  


    

 

1,641

 

  

 

1,136

 

    


  


Operating costs and expenses:

                 

Cost of sales

  

 

1,676

 

  

 

1,162

 

Selling, general and administrative expenses

  

 

40

 

  

 

40

 

Research and development expense

  

 

9

 

  

 

9

 

Loss on sale of assets

  

 

12

 

  

 

—  

 

    


  


    

 

1,737

 

  

 

1,211

 

    


  


Operating loss

  

 

(96

)

  

 

(75

)

Interest expense

  

 

(50

)

  

 

(52

)

Interest income

  

 

1

 

  

 

—  

 

Other income (expense), net

  

 

(1

)

  

 

1

 

    


  


Loss before cumulative effect of accounting change

  

 

(146

)

  

 

(126

)

Cumulative effect of accounting change

  

 

—  

 

  

 

(1,053

)

    


  


Net loss and comprehensive loss

  

$

(146

)

  

$

(1,179

)

    


  


 

 

See Notes to the Consolidated Financial Statements.

 

1


EQUISTAR CHEMICALS, LP

 

CONSOLIDATED BALANCE SHEETS

 

Millions of dollars


  

March 31, 2003


    

December 31, 2002


 

ASSETS

                 

Current assets:

                 

Cash and cash equivalents

  

$

112

 

  

$

27

 

Accounts receivable:

                 

Trade, net

  

 

492

 

  

 

490

 

Related parties

  

 

71

 

  

 

135

 

Inventories

  

 

461

 

  

 

424

 

Prepaid expenses and other current assets

  

 

44

 

  

 

50

 

    


  


Total current assets

  

 

1,180

 

  

 

1,126

 

Property, plant and equipment, net

  

 

3,469

 

  

 

3,565

 

Investments

  

 

65

 

  

 

65

 

Other assets, net

  

 

329

 

  

 

296

 

    


  


Total assets

  

$

5,043

 

  

$

5,052

 

    


  


LIABILITIES AND PARTNERS’ CAPITAL

                 

Current liabilities:

                 

Accounts payable:

                 

Trade

  

$

480

 

  

$

421

 

Related parties

  

 

39

 

  

 

38

 

Current maturities of long-term debt

  

 

332

 

  

 

32

 

Accrued liabilities

  

 

133

 

  

 

223

 

    


  


Total current liabilities

  

 

984

 

  

 

714

 

Long-term debt

  

 

1,896

 

  

 

2,196

 

Other liabilities and deferred revenues

  

 

388

 

  

 

221

 

Commitments and contingencies

                 

Partners’ capital:

                 

Partners’ accounts

  

 

1,812

 

  

 

1,958

 

Accumulated other comprehensive loss

  

 

(37

)

  

 

(37

)

    


  


Total partners’ capital

  

 

1,775

 

  

 

1,921

 

    


  


Total liabilities and partners’ capital

  

$

5,043

 

  

$

5,052

 

    


  


 

See Notes to the Consolidated Financial Statements.

 

2


EQUISTAR CHEMICALS, LP

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

    

For the three months ended March 31,


 

Millions of dollars


  

2003


    

2002


 

Cash flows from operating activities:

                 

Net loss

  

$

(146

)

  

$

(1,179

)

Adjustments to reconcile net loss to cash provided by (used in) operating activities:

                 

Cumulative effect of accounting change

  

 

—  

 

  

 

1,053

 

Depreciation and amortization

  

 

78

 

  

 

73

 

Loss on sale of assets

  

 

12

 

  

 

—  

 

Changes in assets and liabilities that provided (used) cash:

                 

Accounts receivable

  

 

62

 

  

 

(35

)

Inventories

  

 

(49

)

  

 

27

 

Accounts payable

  

 

60

 

  

 

52

 

Other assets and liabilities, net

  

 

50

 

  

 

(110

)

    


  


Cash provided by (used in) operating activities

  

 

67

 

  

 

(119

)

    


  


Cash flows from investing activities:

                 

Proceeds from sale of assets

  

 

35

 

  

 

—  

 

Expenditures for property, plant and equipment

  

 

(13

)

  

 

(15

)

    


  


Cash provided by (used in) investing activities

  

 

22

 

  

 

(15

)

    


  


Cash flows from financing activities:

                 

Net borrowing under lines of credit

  

 

—  

 

  

 

50

 

Repayment of long-term debt

  

 

(1

)

  

 

(101

)

Other

  

 

(3

)

  

 

(2

)

    


  


Cash used in financing activities

  

 

(4

)

  

 

(53

)

    


  


Increase (decrease) in cash and cash equivalents

  

 

85

 

  

 

(187

)

Cash and cash equivalents at beginning of period

  

 

27

 

  

 

202

 

    


  


Cash and cash equivalents at end of period

  

$

112

 

  

$

15

 

    


  


 

 

See Notes to the Consolidated Financial Statements.

 

3


EQUISTAR CHEMICALS, LP

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

1.    Basis of Preparation

 

The accompanying consolidated financial statements are unaudited and have been prepared from the books and records of Equistar Chemicals, LP (“Equistar”) in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X for interim financial information. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments, consisting only of normal, recurring adjustments, considered necessary for a fair presentation have been included. For further information, refer to the consolidated financial statements and notes thereto for the year ended December 31, 2002 included in the Equistar 2002 Annual Report on Form 10-K. Certain amounts from prior periods have been reclassified to conform to the current period presentation.

 

2.    Company Ownership

 

Equistar is a Delaware limited partnership, which commenced operations on December 1, 1997. Prior to August 2002, Equistar was owned 41% by Lyondell Chemical Company (“Lyondell”), 29.5% by Millennium Chemicals Inc. (“Millennium”) and 29.5% by Occidental Petroleum Corporation (“Occidental”). On August 22, 2002, Lyondell completed the purchase of Occidental’s interest in Equistar and, as a result, Lyondell’s ownership interest in Equistar increased to 70.5%.

 

3.   Accounting Changes

 

Equistar has three accounting changes in 2003 and 2002, as discussed below.

 

Variable Interest Entities—In January 2003, the Financial Accounting Standards Board (“FASB”) issued Interpretation No. 46 (“FIN No. 46”), Consolidation of Variable Interest Entities. FIN No. 46 addresses certain situations in which a company should include in its financial statements the assets, liabilities and activities of another entity. FIN No. 46 applies immediately to entities created after January 31, 2003 and, for Equistar, will apply to existing entities beginning in the third quarter 2003. Equistar expects the application of FIN No. 46 to result in the consolidation of an entity from which it leases certain railcars. The consolidation of this entity as of March 31, 2003 would have resulted in a net increase in property, plant and equipment of $114 million, a decrease in prepaid expense of approximately $11 million, a $103 million increase in debt and an immaterial charge reported as the cumulative effect of the accounting change.

 

Early Extinguishment of Debt—In April 2002, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections. The primary impact of the statement on Equistar will be the classification of gains or losses that result from the early extinguishment of debt as an element of income before extraordinary items. Also, gains or losses that were originally reported as extraordinary items in prior periods will be reclassified. This change had no effect on the periods ending March 31, 2003 and 2002.

 

Goodwill and Other Intangible Assets—Effective January 1, 2002, Equistar adopted SFAS No. 142, Goodwill and Other Intangible Assets. Upon implementation of SFAS No. 142, Equistar reviewed goodwill for impairment and concluded that the entire balance of goodwill was impaired, resulting in a $1.1 billion charge that was reported as the cumulative effect of the accounting change as of January 1, 2002. In addition, as a result of implementing SFAS No. 142, earnings in 2002 and subsequent years are favorably affected by $33 million annually because of the elimination of goodwill and its related amortization.

 

4


 

4.    Inventories

 

Inventories consisted of the following:

 

Millions of dollars


  

March 31, 2003


    

December 31, 2002


Finished goods

  

$

256

    

$

233

Work-in-process

  

 

6

    

 

12

Raw materials

  

 

110

    

 

85

Materials and supplies

  

 

89

    

 

94

    

    

Total inventories

  

$

461

    

$

424

    

    

 

5.    Property, Plant and Equipment, Net

 

The components of property, plant and equipment, at cost, and the related accumulated depreciation were as follows:

 

Millions of dollars


  

March 31, 2003


  

December 31, 2002


Land

  

$

77

  

$

80

Manufacturing facilities and equipment

  

 

5,954